Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Journal of Neuropathology and Experimental Neurology - Tập 71 Số 5 - Trang 362-381 - 2012
Peter T. Nelson1,2, Irina Alafuzoff3, Jonathan M. Schott4, Constantin Bouras5, Heiko Braak6, Nigel J. Cairns7,8, Rudolph J. Castellani9, Barbara J. Crain10,11, Peter Davies12,13, Kelly Del Tredici6, Charles Duyckaerts14, Matthew P. Frosch15, Vahram Haroutunian16, Patrick R. Hof17, Christine M. Hulette18,19, Bradley T. Hyman20, Takeshi Iwatsubo21, K. A. Jellinger22, Gregory A. Jicha23,2, Enikò Kövari5, Walter A. Kukull24, James B. Leverenz25,26,27, Seth Love28,29, Ian R. Mackenzie30, David Mann31, Eliezer Masliah32,33, Ann C. McKee34,35, Thomas J. Montine26, John C. Morris7, Julie A. Schneider36,37,26,38, Joshua A. Sonnen39, Dietmar Rudolf Thal40, John Q. Trojanowski41, Juan C. Troncoso42,11, Thomas Wısnıewskı43,44,45,46, Randall L. Woltjer47, Thomas G. Beach48
1Department of Pathology, University of Kentucky, Lexington, Kentucky
2Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky
3Department of Genetics and Pathology, Rudbeck laboratory, Uppsala University, Uppsala, Sweden
4Department of Pathology, Northwestern Alzheimer Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois
5Department of Psychiatry, Geneva University School of Medicine, Geneva, Switzerland
6Section of Clinical Neuroanatomy, Department of Neurology, University of Ulm, Ulm, Germany
7Department of Neurology, Washington University School of Medicine, St. Louis, Missouri
8Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
9Department of Pathology, University of Maryland School of Medicine
10Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland
11Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland
12Department of Pathology, Feinstein Institute of Medical Research, Albert Einstein University, Manhasset, New York
13Dominick P. Purpura Department of Neurosciencey, Feinstein Institute of Medical Research, Albert Einstein University, Manhasset, New York
14Service de Neuropathologie Raymond Escourolle, Hopital de la Salpêtriére, Paris, France
15C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
16Department of Psychiatry, Thse Mount Sinai School of Medicine, New York, New York
17Department of Neuroscience, Thse Mount Sinai School of Medicine, New York, New York
18Department of Neurology, Duke University School of Medicine, Durham, North Carolina
19Department of Pathology, Duke University School of Medicine, Durham, North Carolina
20Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
21Department of Neuropathology, Graduate School of Medicine at the University of Tokyo, Tokyo, Japan
22Institute of Clinical Neurobiology, Vienna, Austria
23Department of Neurology, University of Kentucky, Lexington, Kentucky
24Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington
25Department of Neurology, School of Medicine, University of Washington, Seattle, Washington
26Department of Pathology, School of Medicine, University of Washington, Seattle, Washington
27VA-Puget Sound Health Care System, School of Public Health, University of Washington, Seattle, Washington
28Department of Neuropathology, Institute of Clinical Neurosciences, Frenchay Hospital
29School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
30Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada
31Department of Neuropathology at Hope Hospital, University of Manchester, Salford, United Kingdom
32Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, California
33Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California
34Bedford Veterans Administration Medical Center, Boston University, Bedford, Massachusetts
35Department of Pathology, Boston University, Bedford, Massachusetts
36Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois
37Department of Pathology, Rush University Medical Center, Chicago, Illinois
38Rush University Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois
39Rush University
40Institute of Pathology — Laboratory of Neuropathology, University of Ulm, Ulm, Germany
41Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
42Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland
43Department of Neurology, NYU Langone Medical Center
44Department of Pathology, NYU Langone Medical Center, New York
45Department of Psychiatry, NYU Langone Medical Center, New York
46NYU Alzheimer's Disease Center, NYU Langone Medical Center, New York
47Department of Pathology, Oregon Health and Science University, Portland, Oregon
48Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1007/BF02866241

10.1016/S0197-4580(97)00057-2

10.1007/s00401-011-0910-3

10.1093/jhmas/42.3.327

10.1016/S0010-9452(08)70251-X

10.1016/S0197-4580(98)00052-9

10.1016/j.brainresrev.2005.11.003

10.1002/gps.930050603

10.1093/brain/awn256

10.1016/S0140-6736(96)10203-8

Schneider, 2009, The neuropathology of older persons with and without dementia from community versus clinic cohorts, J Alzheimers Dis, 18, 691, 10.3233/JAD-2009-1227

10.1016/S1474-4422(11)70156-9

Han, 2000, Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: A meta-analysis, Int Psychogeriatr, 12, 231, 10.1017/S1041610200006359

10.1001/archneur.56.7.857

10.1016/S0042-6989(96)00240-4

10.1007/s00401-008-0466-z

10.1212/01.wnl.0000271090.28148.24

10.1097/00005072-197310000-00007

10.1007/BF00688828

10.1097/00005072-196804000-00001

10.1007/s00401-011-0871-6

Masliah, 1995, Mechanisms of synaptic dysfunction in Alzheimer's disease, Histol Histopathol, 10, 509

10.1212/WNL.43.1_Part_1.192

10.1097/01.jnen.0000228136.58062.bf

10.1016/j.ejphar.2006.06.026

Scheff, 2006, Alzheimer's disease-related alterations in synaptic density: Neocortex and hippocampus, J Alzheimers Dis, 9, 101, 10.3233/JAD-2006-9S312

10.1016/S0072-9752(07)01222-5

10.1007/s00401-009-0532-1

10.1016/j.semcdb.2003.12.015

Arai, 2001, Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, cor-ticobasal degeneration and progressive supranuclear palsy, Acta Neu-ropathol, 101, 167, 10.1007/s004010000283

10.1016/S0165-0173(00)00019-9

10.1046/j.1365-2990.2001.00311.x

10.1093/cercor/4.2.138

10.1016/0197-4580(96)00069-3

10.1002/ana.410260614

10.1007/s11010-007-9664-6

10.1007/s00401-007-0237-2

10.1016/0022-510X(70)90063-8

10.1007/s00401-010-0789-4

10.1016/j.neurobiolaging.2008.04.016

10.1097/NEN.0b013e3181aacbe9

Hof, 1996, The neuropathological changes associated with normal brain aging, Histol Histopathol, 11, 1075

10.1111/j.1365-2990.2009.01038.x

10.1097/NEN.0b013e318232a379

10.1016/S0197-4580(97)00065-1

10.1016/S0072-9752(07)01223-7

10.1212/WNL.38.11.1688

Jicha, 2012, Preclinical AD Workgroup staging: Pathological correlates and potential challenges, Neurobiol Aging, 33, 662.e1, 10.1016/j.neurobiolaging.2011.02.018

Terry RD Masliah E Hansen LA . Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD Katzman R Bick KL , eds. Alzheimer Disease. New York, NY: Raven Press, 1994:179–96

Wisniewski HM Vorbrodt AW Moretz RC . Pathogenesis of neuritic (senile) and amyloid plaque formation. Exp Brain Res 1982; Suppl 5:3–9

10.1016/S0197-4580(97)00058-4

Thal, 2000, Sequence of Aβ-protein deposition in the human medial temporal lobe, J Neuropathol Exp Neurol, 59, 733, 10.1093/jnen/59.8.733

10.1126/sageke.2006.6.re1

10.1016/j.neurobiolaging.2009.04.002

Hardy, 2006, Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal, J Alzheimers Dis, 9, 151, 10.3233/JAD-2006-9S317

10.1016/S1474-4422(07)70298-3

10.1111/j.1749-6632.2009.04945.x

10.1016/j.neuron.2010.10.013

10.1001/archpsyc.63.2.168

10.1007/BF00308809

10.1016/0306-4522(95)90397-P

10.1097/NEN.0b013e318177eaf4

10.1111/j.0959-9673.2005.00429.x

Whitehouse, 2011, Describing the dying days of “Alzheimer's disease.”, J Alzheimers Dis, 24, 11, 10.3233/JAD-2010-101639

Chen, 2011, Scientific truth or false hope? Understanding Alzheimer's disease from an aging perspective, J Alz-heimers Dis, 24, 3, 10.3233/JAD-2010-101638

10.1523/JNEUROSCI.4521-10.2010

10.1586/ern.10.27

10.1016/j.arr.2011.03.002

10.1097/01.jnen.0000240466.10758.ce

10.1016/S0140-6736(08)61075-2

10.1212/01.WNL.0000159740.16984.3C

10.1007/s00401-010-0719-5

Roher, 2011, Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient, J Alzheimers Dis, 24, 315, 10.3233/JAD-2011-101809

10.1093/brain/awq056

10.1097/WAD.0b013e3181c53b00

10.1212/WNL.0b013e3181c67808

10.1007/s00401-010-0705-y

10.2174/187152709787847289

Selkoe, 2011, Resolving controversies on the path to Alzheimer's therapeutics, Nat Med, 17, 1521, 10.1038/nm1111-1521d

10.1016/S1474-4422(08)70170-4

10.1038/nrd3505

10.1016/j.bbr.2008.02.016

10.1038/nature02621

10.1111/j.1582-4934.2011.01273.x

Takashima, 2008, Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy, J Alzheimers Dis, 14, 371, 10.3233/JAD-2008-14403

10.1097/YCO.0b013e328314b78b

Delacourte, 2008, Tau pathology and neurodegeneration: An obvious but misunderstood link, J Alzheimers Dis, 14, 437, 10.3233/JAD-2008-14412

10.1016/j.neurobiolaging.2007.02.029

10.1242/jcs.01558

10.1038/nm1782

Jin, 2011, Soluble amyloid {β}-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration, Proc Natl Acad Sci U S A, 108, 5819024, 10.1073/pnas.1017033108

Gadad, 2011, Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-β peptide, J Alzheimers Dis, 24, 223, 10.3233/JAD-2011-110182

10.1523/JNEUROSCI.4456-09.2010

10.1097/NEN.0b013e318217a118

10.1111/j.1750-3639.2010.00374.x

Alafuzoff, 2008, Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe Consortium, Brain Pathol, 18, 484, 10.1111/j.1750-3639.2008.00147.x

10.1007/s12640-010-9190-2

10.1007/BF02189115

10.1007/s00401-006-0127-z

10.1093/cercor/1.1.103

10.1097/00005072-198705000-00003

10.1097/00005072-199311000-00012

10.1111/j.1582-4934.2008.00411.x

10.1002/ana.22112

10.1111/j.1750-3639.2008.00244.x

10.1212/01.WNL.0000129697.01779.0A

10.1371/journal.pmed.1000180

10.1002/ana.21208

10.1097/00002093-199910000-00009

10.1891/cmaj.6.2.107

Schneider, 2009, The neuropathology of older persons with and without dementia from community versus clinic cohorts, J Alzheimers Dis, 18, 691, 10.3233/JAD-2009-1227

10.1111/j.1532-5415.1999.tb02571.x

10.1186/1471-2377-8-48

10.1093/brain/awg204

10.1093/ageing/afm120

10.1111/j.1440-1789.2006.00722.x

Ulrich J Spillantini MG Goedert M . Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1992:257–84

10.1007/s00401-006-0156-7

10.1002/ana.410400204

10.1159/000051245

10.1007/s00401-006-0053-0

10.1212/WNL.40.6.975

10.1002/ana.410220411

Wong, 1996, An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic Parkinsonism, Clin Neuropathol, 15, 22

Jellinger, 1998, Senile dementia with tangles (tangle predominant form of senile dementia), Brain Pathol, 8, 367, 10.1111/j.1750-3639.1998.tb00160.x

10.1001/archneur.60.8.1119

Aronson, 1991, Dementia, Age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med, 151, 989

Katzman R Kawas C . The epidemiology of dementia and Alzheimer disease. In: Terry RD , ed. Alzheimer Disease. New York, NY: Raven Press, Ltd, 1994:105–22

10.1212/01.wnl.0000247041.63081.98

10.1136/jnnp.2004.053645

10.1037/0882-7974.19.4.592

10.1212/01.wnl.0000259542.54830.34

10.1126/sageke.2004.23.pe26

10.1001/archneur.62.5.758

10.1586/14737175.4.5.831

10.1148/radiol.2293021299

10.1037/0894-4105.19.4.520

10.1093/brain/124.1.96

10.1016/j.jalz.2010.12.002

10.1016/j.jalz.2011.03.004

Central Intelligence Agency. The World Factbook. Washington, DC: Central Intelligence Agency, 2008

10.1097/NEN.0b013e3181919a48

10.1016/j.neuroimage.2009.01.004

10.1002/jmri.21049

Sonnen, 2010, Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia, J Alzheimers Dis, 19, 301, 10.3233/JAD-2010-1236

10.1001/jama.280.14.1245

10.1034/j.1600-0463.2001.d01-145.x

10.1212/01.wnl.0000219668.47116.e6

10.1097/NEN.0b013e31822e8ae9

10.1001/archneurol.2011.157

Abner, 2011, “End-stage” neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?, J Alzheimers Dis, 25, 445, 10.3233/JAD-2011-101980

10.1212/WNL.42.9.1681

10.1001/archneur.1993.00540040011008

10.1002/ana.410340410

10.1016/0197-4580(92)90027-U

10.1002/ana.21031

Erkinjuntti, 1987, Suspected dementia: Evaluation of 323 consecutive referrals, Acta Neurol Scand, 76, 359, 10.1111/j.1600-0404.1987.tb03594.x

10.1001/archneur.56.6.713

10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X

10.1212/WNL.55.3.370

10.1002/ana.410430519

10.1111/j.1749-6632.2000.tb06404.x

Knopman, 2003, Neuropathology of cognitively normal elderly, J Neuropathol Exp Neurol, 62, 1087, 10.1093/jnen/62.11.1087

10.1046/j.0919-6544.2001.00425.x

10.1097/00005072-199812000-00009

10.5414/NP300418

10.1007/s00401-009-0612-2

10.1001/archneur.57.5.713

10.1016/S0140-6736(00)03589-3

10.1001/archneur.65.9.1211

10.1056/NEJMoa0806142

von Gunten A Ebbing K Imhof A . Brain aging in the oldest-old. [published online ahead of print July 25, 2010] Curr Gerontol Geriatr Res

10.1177/0891988706297086

10.1007/s004010050512

10.1001/archpsyc.55.3.225

10.1007/s004010050969

Leinonen V Koivisto AM Savolainen S . Post-mortem findings in 10 patients with presumed normal pressure hydrocephalus and review of the literature. [published online ahead of print February 10, 2012] Neuropathol Appl Neurobiol

10.1007/s00701-002-0936-3

10.1001/archneur.59.11.1737

10.1093/oxfordjournals.aje.a009560

10.1212/01.wnl.0000176053.98907.3f

10.1016/j.jalz.2010.11.002

10.1016/j.jalz.2010.11.003

10.1002/ana.21915

10.1016/j.jns.2007.01.025

10.1007/s00401-010-0654-5

10.1126/science.8346443

10.1093/brain/awq141

10.1097/nen.0b013e31815c5efb

10.1212/WNL.0b013e3181f39adc

10.1093/brain/awr308

10.1136/jnnp.64.1.18

10.1016/j.jns.2004.09.004

10.1016/j.jns.2007.01.045

10.1002/ana.21142

10.1212/01.WNL.0000118211.78503.F5

10.1016/0022-510X(75)90116-1

10.1002/ana.21009

10.1001/archneur.63.5.674

10.1017/S1041610203008949

10.1212/01.wnl.0000257094.10655.9a

10.1093/brain/awm228

Murray, 2007, Vascular dementia: Clinical, neuroradiologic and neuropathologic aspects, Panminerva Med, 49, 197

10.1016/0022-510X(90)90072-U

10.1111/j.1749-6632.2002.tb04794.x

10.1177/0891988705281872

10.1212/WNL.0b013e318200d6f9

10.1111/j.1749-6632.2002.tb04807.x

Thal, 2003, Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline, J Neuropathol Exp Neurol, 62, 1287, 10.1093/jnen/62.12.1287

10.1093/brain/awq321

10.1093/brain/awr053

10.1007/s00401-006-0183-4

10.1016/j.bbrc.2006.10.093

10.1212/WNL.48.1.154

10.1001/archneur.1993.00540040051014

10.1001/archneur.63.2.218

10.1097/WAD.0b013e31820f8f50

10.1093/brain/awr053

10.1016/S1474-4422(04)00949-4

10.1111/j.1365-2990.2005.00635.x

10.1016/j.maturitas.2011.07.008

10.1007/s00401-011-0826-y

10.1001/archneur.60.5.729

10.1001/archneur.63.1.38

10.1001/archneur.55.3.326

10.1016/S0197-4580(96)00170-4

10.1212/WNL.45.1.178

10.1001/archneur.63.2.226

10.1212/01.wnl.0000284603.85621.aa

10.1001/archneur.56.12.1458

10.1097/00005072-199708000-00011

10.1001/archpsyc.59.10.946

10.1016/j.neulet.2004.01.044

10.1002/ana.410270502

10.1212/WNL.54.1.105

10.1212/01.WNL.0000165987.89198.65

10.1001/archneur.58.8.1243

10.1007/s004010051163

10.1097/00006842-200205000-00014

Duyckaerts, 1990, Rating of the lesions in senile dementia of the Alzheimer type: Concordance between laboratories, A European multicenter study under the auspices of EURAGE. J Neurol Sci, 97, 295

Yasha, 1997, Histopathological & immuno-histochemical evaluation of ageing changes in normal human brain, Indian J Med Res, 105, 141

10.1016/j.neulet.2008.11.006

Caramelli, 1998, Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease, Neuropsychiatry Neuropsychol Behav Neurol, 11, 184

10.1007/BF00687751

10.1007/BF00687893

McKeel, 2004, Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type, J Neuropathol Exp Neurol, 63, 1028, 10.1093/jnen/63.10.1028

10.1097/60.10.946

Masliah, 1990, Diffuse plaques do not accentuate synapse loss in Alzheimer's disease, Am J Pathol, 137, 1293

10.1097/00005072-199507000-00009

Duyckaerts, 1998, Progression of Alzheimer histopathological changes, Acta Neurol Belg, 98, 180

10.1016/0197-4580(95)00013-5

10.2174/156720510791162340

10.1212/01.WNL.0000115115.98960.37

10.1192/bjp.114.512.797

10.1038/209109a0

10.1016/0022-510X(68)90154-8

10.1007/s00401-011-0831-1

10.1007/s00401-009-0538-8

10.1016/S0306-4522(02)00056-8

10.1212/01.wnl.0000304041.09418.b1

10.1002/ana.410300206

10.1212/WNL.58.12.1791

Beach, 2012, Striatal amyloid plaque density predicts braak neurofibrillary stage and clinicopathological Alzheimer's disease: Implications for amyloid imaging, J Alzheimers Dis, 28, 869, 10.3233/JAD-2011-111340

10.1001/archneur.61.3.378

10.1016/0165-6147(91)90609-V

10.1038/nature08890

10.1074/jbc.M808759200

10.1038/ncb1901

10.1074/jbc.M110.209296

10.1016/0197-4580(93)90043-B

10.1038/nm840

10.1097/NEN.0b013e3182345e46

10.1097/00005072-199311000-00009

10.1515/REVNEURO.2004.15.4.267

10.1073/pnas.0811698106

10.1016/0006-8993(93)90145-D

10.1016/0306-4522(89)90431-4

10.1016/S0166-2236(00)01749-5

10.1002/cne.903340203

10.1016/0304-3940(88)90706-9

10.1016/0006-8993(89)90812-3

10.1007/s00415-009-5324-y

10.1007/BF00687379

Morrison, 1991, An anatomic substrate for visual disconnection in Alzheimer's disease, Ann N Y Acad Sci, 640, 36, 10.1111/j.1749-6632.1991.tb00187.x

10.1002/cne.10760

Lewis, 1987, Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices, J Neurosci, 7, 1799, 10.1523/JNEUROSCI.07-06-01799.1987

10.1016/S0197-4580(97)80306-5

10.1002/ana.10161

10.1159/000197881

10.1212/01.wnl.0000324924.91351.7d

10.1001/archneur.1995.00540250089017

Brayne, 2009, Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study, J Alzheimers Dis, 18, 645, 10.3233/JAD-2009-1182

10.1212/WNL.42.3.631

10.1016/S0197-4580(99)00063-9

10.1159/000106918

10.1159/000017111

10.1016/0022-3956(75)90026-6

10.1016/0197-4580(95)00021-6

10.1159/000116984

10.1016/S0197-4580(97)00047-X

10.1016/j.neurobiolaging.2006.02.007

10.1097/00005072-199704000-00010

10.1007/s00401-001-0475-7

10.1002/ana.410410106

10.1016/0304-3940(95)12083-G

10.1001/archneur.64.8.1193

10.1007/s00401-001-0477-5

10.1006/exnr.1998.6852

10.1016/S0306-4522(02)00942-9

10.1016/j.tins.2004.07.013

10.1016/0304-3940(85)90439-2

Mann, 1985, Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit, Clin Neuropathol, 4, 127

10.1007/BF00687664

10.1007/BF00687663

Wisniewski, 1968, Further studies on experimental neurofibrillary tangles, J Neuropathol Exp Neurol, 27, 149

10.1097/00005072-196310000-00005

10.1007/BF00692056

10.1001/archneur.1962.04210030065009

10.1016/0022-510X(82)90155-1

10.1016/0022-510X(82)90045-4

10.1093/brain/awr308

10.1007/s00702-010-0574-5

10.1007/BF00293396

10.1007/s004010051164

10.1159/000106745

10.1007/BF00296494

10.1097/NEN.0b013e31817d7a1d

10.1007/978-3-7091-6846-2_9

10.1097/NEN.0b013e3181a9d503

10.1007/BF00304630

10.1136/jnnp.53.5.373

10.1007/BF00318566

Mattsson, 2011, gamma-Secretase-dependent amyloid-β is increased in Niemann-Pick Type C: A cross-sectional study, Neurology, 76, 366, 10.1212/WNL.0b013e318208f4ab

10.1007/s004010050774

10.1097/60.11.1075

10.1093/brain/84.4.662

10.1016/0006-8993(91)91467-F

10.1016/0006-8993(94)90212-7

10.1111/j.1445-5994.2006.01153.x

10.1007/s12031-011-9589-0

10.1016/0306-4522(95)00331-C

Haroutunian, 2009, Is there a neuropathology difference between mild cognitive impairment and dementia?, Dialogues Clin Neurosci, 11, 171, 10.31887/DCNS.2009.11.2/vharoutunian

10.1007/BF00304135

10.1159/000017050

10.1016/S0002-9440(10)64573-7

10.1212/WNL.58.5.750

10.1212/01.WNL.0000152982.47274.9E

Dowling NM Tomaszewski Farias S Reed BR . Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc 2010:1–13

10.1002/ana.20318

Haneuse, 2009, Neuropathology-based risk scoring for dementia diagnosis in the elderly, J Alzheimers Dis, 17, 875, 10.3233/JAD-2009-1105

10.1097/WAD.0b013e318199d833